AstraZeneca (United Kingdom) (Q331549): Difference between revisions

From geokb

Revision as of 14:39, 10 September 2024

company organization in Cambridge, United Kingdom

Language	Label	Description	Also known as
English	AstraZeneca (United Kingdom)	company organization in Cambridge, United Kingdom

Statements

0 references

addresses subject

Advancements in Lung Cancer Research

802

1 reference

https://openalex.org/I105036370

Computational Methods in Drug Discovery

689

1 reference

https://openalex.org/I105036370

Chiral Separation in Chromatography

625

1 reference

https://openalex.org/I105036370

Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy

585

1 reference

https://openalex.org/I105036370

574

1 reference

https://openalex.org/I105036370

Genomic Landscape of Cancer and Mutational Signatures

482

1 reference

https://openalex.org/I105036370

Drug Metabolism and Pharmacogenomics

435

1 reference

https://openalex.org/I105036370

Peptide Synthesis and Drug Discovery

417

1 reference

https://openalex.org/I105036370

Standardisation and Management of COPD

403

1 reference

https://openalex.org/I105036370

Advancements in Colorectal Cancer Research

374

1 reference

https://openalex.org/I105036370

Cancer Immunotherapy

373

1 reference

https://openalex.org/I105036370

Therapeutic Antibodies: Development, Engineering, and Applications

359

1 reference

https://openalex.org/I105036370

Health Economics and Quality of Life Assessment

354

1 reference

https://openalex.org/I105036370

HER2 Signaling in Breast Cancer Treatment

350

1 reference

https://openalex.org/I105036370

Mechanisms of Multidrug Resistance in Cancer

335

1 reference

https://openalex.org/I105036370

Molecular Mechanisms of DNA Damage Response

332

1 reference

https://openalex.org/I105036370

mTOR Signaling in Growth and Disease

326

1 reference

https://openalex.org/I105036370

Statistical Methods in Clinical Trials and Drug Development

311

1 reference

https://openalex.org/I105036370

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

303

1 reference

https://openalex.org/I105036370

Genotoxicity and Carcinogenesis Mechanisms

292

1 reference

https://openalex.org/I105036370

Advances in Metabolomics Research

289

1 reference

https://openalex.org/I105036370

Animal Research Studies

284

1 reference

https://openalex.org/I105036370

Management of Diabetes Mellitus and Cardiovascular Risk

281

1 reference

https://openalex.org/I105036370

Mechanisms of Estrogen Receptor Signaling

270

1 reference

https://openalex.org/I105036370

Structure and Function of G Protein-Coupled Receptors

270

1 reference

https://openalex.org/I105036370

coordinate location

51°31'11"N, 0°10'54"W

1 reference

https://openalex.org/I105036370

United Kingdom of Great Britain and Northern Ireland

1 reference

https://openalex.org/I105036370

official website

http://www.astrazeneca.co.uk/home

1 reference

https://openalex.org/I105036370

0 references

Research Organization Registry ID

0 references

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q331549&oldid=1267969"